Skip to main content
Clinical Trials/NCT01820650
NCT01820650
Terminated
Not Applicable

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

Restor3D9 sites in 1 country359 target enrollmentFebruary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoarthritis of the Knee
Sponsor
Restor3D
Enrollment
359
Locations
9
Primary Endpoint
2011 Knee Society Score
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis.

Detailed Description

If the patient has previously received a standard total knee replacement in their contralateral knee, the primary endpoint questionnaire and some secondary endpoint questionnaires will be completed regarding BOTH their iTotal® CR knee and their standard total knee for all time points where questionnaires are required by the protocol.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
October 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Restor3D
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical condition included in the approved Indications For Use for the iTotal® CR
  • Osteoarthritis, as confirmed by the investigator's assessment of disease status at screening visit that warrants a TKR procedure. Disease status is assessed by Clinical and Radiographic assessment.
  • Willingness to participate in the clinical study, to give informed consent and to attend all follow-up visits
  • \> 18 years of age

Exclusion Criteria

  • Simultaneous bilateral procedure required
  • BMI \> 40
  • Active malignancy (defined as a history of any invasive malignancy - except non-melanoma skin cancer), unless patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years
  • Poorly Controlled diabetes
  • Neuromuscular conditions which prevent patient from participating in study activities
  • Active local or systemic infection
  • Immunocompromised
  • Fibromyalgia or other general body pain related condition
  • Rheumatoid arthritis or other forms of inflammatory joint disease
  • Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in the area of the joint to be operated to an extent that the procedure is unjustified

Outcomes

Primary Outcomes

2011 Knee Society Score

Time Frame: 1 Year

Study Sites (9)

Loading locations...

Similar Trials